Recommended Screening and Preventive Practices for Long-Term Survivors after Hematopoietic Cell TransplantationNavneet S. Majhail, André Tichelli, Shinichiro Okamoto et al.|Biology of Blood and Marrow Transplantation|2011Cited by 363
Hematopoietic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the Worldwide Network for Blood and Marrow Transplantation Group including the global surveyD Niederwieser, Helen Baldomero, Jeff Szer et al.|Bone Marrow Transplantation|2016Cited by 309
One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donorsDietger Niederwieser, Wael Saber, Helen Baldomero et al.|Haematologica|2021Cited by 236
Metabolic Syndrome and Cardiovascular Disease after Hematopoietic Cell Transplantation: Screening and Preventive Practice Recommendations from the CIBMTR and EBMTZachariah DeFilipp, Bronwen E. Shaw, Rafael F. Duarte et al.|Biology of Blood and Marrow Transplantation|2016Cited by 64
International Recommendations for Screening and Preventative Practices for Long-Term Survivors of Transplantation and Cellular Therapy: A 2023 UpdateSeth J. Rotz, Rachel Phelan, Neel S. Bhatt et al.|Transplantation and Cellular Therapy|2024Cited by 62